Literature DB >> 11275431

Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma.

W Naidong1, P R Ring, C Midtlien, X Jiang.   

Abstract

A liquid chromatography-tandem mass spectrometry method (LC-MS-MS) was developed and validated for measuring warfarin (WAR) enantiomers (R-WAR and S-WAR) in human EDTA plasma. Liquid-liquid extraction using ethyl ether was used to extract the analytes from the plasma. Baseline resolution of S- and R-WAR as well as the internal standard enantiomers (S- and R-p-ClWAR, S-IS and R-IS) was achieved on a beta-cyclodextrin column with a mobile phase of acetonitrile-acetic acid-triethylamine (1000:3:2.5, v/v/v). The retention times are 6.9, 8.0, 7.0, and 7.9 min for S-WAR, R-WAR, S-IS and R-IS, respectively. The detection was by monitoring S- and R-WAR at m/z 307-->161 and S- and R-IS at m/z 341-->161 using (-) ESI. The standard curve range was 1-100 ng ml(-1) for both S- and R-WAR. The inter-day precision and accuracy of the quality control (QC) samples were <7.3% relative standard deviation (RSD) and <7.3% bias for S-WAR, and <6.5% RSD and <5.8% bias for R-WAR, respectively. Analyte stability during sample processing and storage were established. Method ruggedness was demonstrated by the reproducible performance from analysis of clinical samples.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11275431     DOI: 10.1016/s0731-7085(00)00476-3

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects.

Authors:  Walter Dieterle; Sophie Corynen; Jessica Mann
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 2.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Effect of single-dose rifampin on the pharmacokinetics of warfarin in healthy volunteers.

Authors:  A Frymoyer; S Shugarts; M Browne; A H B Wu; L Frassetto; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  2010-08-11       Impact factor: 6.875

4.  A chiral HPLC-MS/MS method for simultaneous quantification of warfarin enantiomers and its major hydroxylation metabolites of CYP2C9 and CYP3A4 in human plasma.

Authors:  W Ju; K Peng; S Yang; H Sun; M Sampson; M Z Wang
Journal:  Austin J Anal Pharm Chem       Date:  2014

5.  Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.

Authors:  Xiaochun Wang; Jingguo Hou; Michael Jann; Yuen Yi Hon; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2012-11-26       Impact factor: 4.759

6.  Validation and Application of a Simple UHPLC-MS-MS Method for the Enantiospecific Determination of Warfarin in Human Urine.

Authors:  Osama Y Alshogran; Andrew J Ocque; François A Leblond; Vincent Pichette; Thomas D Nolin
Journal:  J Chromatogr Sci       Date:  2015-12-11       Impact factor: 1.618

7.  Separation and determination of warfarin enantiomers in human plasma using a novel polymeric surfactant for micellar electrokinetic chromatography-mass spectrometry.

Authors:  Jingguo Hou; Jie Zheng; Shahab A Shamsi
Journal:  J Chromatogr A       Date:  2007-04-21       Impact factor: 4.759

8.  Effect of tanshinone IIA on the noncovalent interaction between warfarin and human serum albumin studied by electrospray ionization mass spectrometry.

Authors:  Jie Liu; Xiaoru Wang; Zongwei Cai; Frank S C Lee
Journal:  J Am Soc Mass Spectrom       Date:  2008-06-28       Impact factor: 3.109

9.  Chirality and structure-selective MALDI using mold matrix.

Authors:  Yosuke Fujii; Jiawei Xu; Tatsuya Fujino
Journal:  Sci Rep       Date:  2018-09-03       Impact factor: 4.379

10.  VKORC1 and CYP2C9 Genotype Variations in Relation to Warfarin Dosing in Korean Stroke Patients.

Authors:  Sea Mi Park; Jong-Keuk Lee; Sa Il Chun; Hae In Lee; Sun U Kwon; Dong-Wha Kang; Jong S Kim
Journal:  J Stroke       Date:  2013-05-31       Impact factor: 6.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.